Energetic delayed hadrons in large air showers observed at 5200m above sea level

Energetic delayed hadrons in air showers with electron sizes in the range 10 to the 6th power to 10 to the 9th power were studied by observing the delayed bursts produced in the shield of nine square meter scintillation detectors in the Chacaltaya air-shower array. The frequency of such delayed burst is presented as a function of electron size, core distance and sec theta

Size distributions of air showers accompanied with high energy gamma ray bundles observed at Mt. Chacaltaya

Size distributions of air showers accompanied with bundle of high energy gamma rays and/or large size bursts under emulsion chambers, to study the composition of primary cosmic rays and also characteristics of high energy nuclear interaction. Air showers initiated by particles with a large cross section of interaction may develop from narrow region of the atmosphere near the top. Starting levels of air showers by particles with smaller cross section fluctuate in wider region of the atmosphere. Air showers of extremely small size accompanied with bundle of gamma rays may be ones initiated by protons at lower level after penetrating deep atmosphere without interaction. It is determined that the relative size distribution according to the total energy of bundle of gamma rays and the total burst size observed under 15 cm lead absorber

Programmed Death (PD)-1-Deficient Mice Are Extremely Sensitive to Murine Hepatitis Virus Strain-3 (MHV-3) Infection

The inhibitory receptor programmed death-1 (PD-1) has the capacity to maintain peripheral tolerance and limit immunopathological damage; however, its precise role in fulminant viral hepatitis (FH) has yet to be described. Here, we investigated the functional mechanisms of PD-1 as related to FH pathogenesis induced by the murine hepatitis virus strain-3 (MHV-3). High levels of PD-1-positive CD4+, CD8+ T cells, NK cells and macrophages were observed in liver, spleen, lymph node and thymus tissues following MHV-3 infection. PD-1-deficient mice exhibited significantly higher expression of the effector molecule which initiates fibrinogen deposition, fibrinogen-like protein 2 (FGL2), than did their wild-type (WT) littermates. As a result, more severe tissue damage was produced and mortality rates were higher. Fluorescence double-staining revealed that FGL2 and PD-1 were not co-expressed on the same cells, while quantitative RT-PCR demonstrated that higher levels of IFN-γ and TNF-α mRNA transcription occurred in PD-1-deficient mice in response to MHV-3 infection. Conversely, in vivo blockade of IFN-γ and TNF-α led to efficient inhibition of FGL2 expression, greatly attenuated the development of tissue lesions, and ultimately reduced mortality. Thus, the up-regulation of FGL2 in PD-1-deficient mice was determined to be mediated by IFN-γ and TNF-α. Taken together, our results suggest that PD-1 signaling plays an essential role in decreasing the immunopathological damage induced by MHV-3 and that manipulation of this signal might be a useful strategy for FH immunotherapy

When the strategies for cellular selectivity fail. Challenges and surprises in the design and application of fluorescent benzothiadiazole derivatives for mitochondrial staining

This work describes a series of fluorescent 2,1,3-benzothiadiazole derivatives (neutral, singly-charged and doubly-charged) to act as bioprobes for mitochondria. The results showed the flaws in the molecular architecture of this class of fluorophores and our attempts to direct the synthesized derivatives to the organelle. Unexpected results also showed a need for new strategies to predict the cellular selectivity of these derivatives. One of the singly-charged derivatives could stain mitochondria selectively whereas the doubly-charged stained the plasma membrane in an unexpected but highly selective manner. Co-staining experiments confirmed the cellular localization of the new derivatives. EPR experiments demonstrated the fluorescent marker that is selective for mitochondria does not interfere in the ROS production of the cells

The impact of surgical delay on resectability of colorectal cancer: An international prospective cohort study

AIM: The SARS-CoV-2 pandemic has provided a unique opportunity to explore the impact of surgical delays on cancer resectability. This study aimed to compare resectability for colorectal cancer patients undergoing delayed versus non-delayed surgery. METHODS: This was an international prospective cohort study of consecutive colorectal cancer patients with a decision for curative surgery (January-April 2020). Surgical delay was defined as an operation taking place more than 4 weeks after treatment decision, in a patient who did not receive neoadjuvant therapy. A subgroup analysis explored the effects of delay in elective patients only. The impact of longer delays was explored in a sensitivity analysis. The primary outcome was complete resection, defined as curative resection with an R0 margin. RESULTS: Overall, 5453 patients from 304 hospitals in 47 countries were included, of whom 6.6% (358/5453) did not receive their planned operation. Of the 4304 operated patients without neoadjuvant therapy, 40.5% (1744/4304) were delayed beyond 4 weeks. Delayed patients were more likely to be older, men, more comorbid, have higher body mass index and have rectal cancer and early stage disease. Delayed patients had higher unadjusted rates of complete resection (93.7% vs. 91.9%, P = 0.032) and lower rates of emergency surgery (4.5% vs. 22.5%, P < 0.001). After adjustment, delay was not associated with a lower rate of complete resection (OR 1.18, 95% CI 0.90-1.55, P = 0.224), which was consistent in elective patients only (OR 0.94, 95% CI 0.69-1.27, P = 0.672). Longer delays were not associated with poorer outcomes. CONCLUSION: One in 15 colorectal cancer patients did not receive their planned operation during the first wave of COVID-19. Surgical delay did not appear to compromise resectability, raising the hypothesis that any reduction in long-term survival attributable to delays is likely to be due to micro-metastatic disease